Login

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role 2025 pay Source
Sigurdur O. Olafsson Also a director
President, Chief Executive Officer and Director
57 Since 2022
4 years
$47,351,608
Christiana Stamoulis
President and Chief Financial Officer
55 Since 2025
1 year
$9,904,539
Tracy Basso
Executive Vice President and Chief Human Resources Officer
51 Since 2025
1 year
Not reported
Lisa French
Executive Vice President and Chief Commercial Officer
57 Since 2022
4 years
$8,495,310
Marek Honczarenko
Executive Vice President and Chief Scientific Officer
56 Since 2025
1 year
Not reported
Henriette Nielsen
Executive Vice President and Chief Transformation Officer
60 Since 2022
4 years
$8,554,745
Paul O'Neill
Executive Vice President and Chief Operations Officer
56 Since 2025
1 year
Not reported
Cheryl Stouch
EVP & Chief Info Officer
Title from the Form 4 dated Jul 21, 2026
54 Not stated Not reported
Mark Tyndall
Executive Vice President, Chief Legal Officer and Corporate Secretary
50 Since 2022
4 years
$8,470,274
Susan Williamson
Executive Vice President and Chief Compliance Officer
50 Since 2025
1 year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
7 of 9
stated in the proxy
Average tenure
1.9 years
from year joined
CEO also chairs the board
No
Marc Yoskowitz
Director On board Independent Committees Other public boards 2025 pay Source
Marc Yoskowitz
Not stated Independent None stated Mereo BioPharma $578,908
Sigurdur O. Olafsson
2022
4 years
Not independent None stated None stated Paid as CEO
Paul M. Bisaro
Not stated Independent
Governance and Compliance Committee · Chair
Pleo Pharma, Zoetis Inc., Myriad Genetics, Inc. $6,017,011
Leslie Donato
2025
1 year
Independent None stated RIS Rx $417,615
Katina Dorton
2024
2 years
Independent None stated Fulcrum Therapeutics, TScan Therapeutics, Sonoma Bio, Prelude Therapeutics $3,815,307
Paul Efron
2025
1 year
Independent
Governance and Compliance Committee
None stated $593,505
Scott Hirsch
2025
1 year
Not independent None stated None stated $5,783,257
Sophia Langlois
2025
1 year
Independent
Audit Committee · Chair
Pason Systems Inc. $435,967
Jonathan Zinman
2023
3 years
Independent
Audit Committee
MP Topco Holdings, LLC $4,883,660

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 27, 2026
Paul Efron
a member of the Board
$709,972
2025

Sale of 7,692 ordinary shares to Paul Efron in a private placement, at a price equal to the cash he would have received for cancelling his outstanding RSUs at the Merger Effective Time.

Scott Hirsch
a member of the Board
Amount not stated
2025

Compensation received by Scott Hirsch under his Noncompetition and Consulting Agreement.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support